| Literature DB >> 30661239 |
Paola Nicoletti1,2, Guruprasad P Aithal3, Thomas C Chamberlain4,5, Sally Coulthard4, Mohammad Alshabeeb4,6, Jane I Grove3,7, Raul J Andrade8,9, Einar Bjornsson10, John F Dillon11, Par Hallberg12, M Isabel Lucena8,9, Anke H Maitland-van der Zee13, Jennifer H Martin14, Mariam Molokhia15, Munir Pirmohamed16, Mia Wadelius12, Yufeng Shen17,18, Matthew R Nelson19, Ann K Daly4.
Abstract
Some patients prescribed flucloxacillin (~ 0.01%) develop drug-induced liver injury (DILI). HLA-B*57:01 is an established genetic risk factor for flucloxacillin DILI. To consolidate this finding, identify additional genetic factors, and assess relevance of risk factors for flucloxacillin DILI in relation to DILI due to other penicillins, we performed a genomewide association study involving 197 flucloxacillin DILI cases and 6,835 controls. We imputed single-nucleotide polymorphism and human leukocyte antigen (HLA) genotypes. HLA-B*57:01 was the major risk factor (allelic odds ratio (OR) = 36.62; P = 2.67 × 10-97 ). HLA-B*57:03 also showed an association (OR = 79.21; P = 1.2 × 10-6 ). Within the HLA-B protein sequence, imputation showed valine97 , common to HLA-B*57:01 and HLA-B*57:03, had the largest effect (OR = 38.1; P = 9.7 × 10-97 ). We found no HLA-B*57 association with DILI due to other isoxazolyl penicillins (n = 6) or amoxicillin (n = 15) and no significant non-HLA signals for any penicillin-related DILI.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30661239 DOI: 10.1002/cpt.1375
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875